{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T02:30:22Z","timestamp":1771641022394,"version":"3.50.1"},"reference-count":24,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2020,2,29]],"date-time":"2020-02-29T00:00:00Z","timestamp":1582934400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["(PG\/14\/97\/31263)"],"award-info":[{"award-number":["(PG\/14\/97\/31263)"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["(RE\/13\/5\/30177)"],"award-info":[{"award-number":["(RE\/13\/5\/30177)"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2020,1,3]]},"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>There is conflicting evidence regarding the benefits of percutaneous coronary intervention (PCI) in patients with grey zone fractional flow reserve (<jats:sup>GZ<\/jats:sup>FFR artery) values (0.75\u20130.80). The prevalence of ischaemia is unknown. We wished to define the prevalence of ischaemia in <jats:sup>GZ<\/jats:sup>FFR artery and assess whether PCI is superior to optimal medical therapy (OMT) for angina control.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We enrolled 104 patients with angina with 1:1 randomisation to PCI or OMT. The artery was interrogated with a Doppler flow\/pressure wire. Patients underwent Magnetic Resonance Imaging (MRI) with follow-up at 3 and 12 months. The primary outcome was angina status at 3 months using the Seattle Angina Questionnaire (SAQ).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>104 patients (age 60\u00b19 years), 79 (76%) males and 79 (76%) Left Anterior Descending (LAD) stenoses were randomised. Coronary physiology and SAQ were similar. Of 98 patients with stress perfusion MRI data, 17 (17%) had abnormal perfusion (\u22652 segments with \u226525% ischaemia or \u22651 segment with \u226550% ischaemia) in the target <jats:sup>GZ<\/jats:sup>FFR artery. Of 89 patients with invasive physiology data, 26 (28%) had coronary flow velocity reserve &lt;2.0 in the target <jats:sup>GZ<\/jats:sup>FFR artery. After 3 months of follow-up, compared with patients treated with OMT only, patients treated by PCI and OMT had greater improvements in SAQ angina frequency (21 (28) vs 10 (23); p=0.026) and quality of life (24 (26) vs 11 (24); p=0.008) though these differences were no longer significant at 12 months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Non-invasive evidence of major ischaemia is uncommon in patients with <jats:sup>GZ<\/jats:sup>FFR artery. Compared with OMT alone, patients randomised to undergo PCI reported improved symptoms after 3 months but these differences were no longer significant after 12 months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial results\" xlink:href=\"NCT02425969\">NCT02425969<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2019-316075","type":"journal-article","created":{"date-parts":[[2020,2,29]],"date-time":"2020-02-29T17:25:14Z","timestamp":1582997114000},"page":"758-764","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial"],"prefix":"10.1136","volume":"106","clinical-trial-number":[{"clinical-trial-number":"nct02425969","registry":"10.18810\/clinical-trials-gov","type":"results"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3325-5718","authenticated-orcid":false,"given":"Barry","family":"Hennigan","sequence":"first","affiliation":[{"name":"Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom"},{"name":"BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK"},{"name":"Cardiology Department, The Mater Private Hospital Cork, Cork, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4547-8636","authenticated-orcid":false,"given":"Colin","family":"Berry","sequence":"additional","affiliation":[{"name":"Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom"},{"name":"BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Collison","sequence":"additional","affiliation":[{"name":"Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom"},{"name":"BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Corcoran","sequence":"additional","affiliation":[{"name":"BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hany","family":"Eteiba","sequence":"additional","affiliation":[{"name":"Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom"},{"name":"BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Good","sequence":"additional","affiliation":[{"name":"Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"McEntegart","sequence":"additional","affiliation":[{"name":"Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom"},{"name":"BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Watkins","sequence":"additional","affiliation":[{"name":"Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D","family":"McClure","sequence":"additional","affiliation":[{"name":"BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3505-7440","authenticated-orcid":false,"given":"Kenneth","family":"Mangion","sequence":"additional","affiliation":[{"name":"BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4009-6652","authenticated-orcid":false,"given":"Thomas Joseph","family":"Ford","sequence":"additional","affiliation":[{"name":"BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C","family":"Petrie","sequence":"additional","affiliation":[{"name":"BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Hood","sequence":"additional","affiliation":[{"name":"Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom"},{"name":"BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Rocchiccioli","sequence":"additional","affiliation":[{"name":"Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom"},{"name":"BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aadil","family":"Shaukat","sequence":"additional","affiliation":[{"name":"Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell","family":"Lindsay","sequence":"additional","affiliation":[{"name":"Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7842-3463","authenticated-orcid":false,"given":"Keith G","family":"Oldroyd","sequence":"additional","affiliation":[{"name":"Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom"},{"name":"BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,2,29]]},"reference":[{"key":"2025092000532464000_106.10.758.1","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezu366"},{"key":"2025092000532464000_106.10.758.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199606273342604"},{"key":"2025092000532464000_106.10.758.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.872358"},{"key":"2025092000532464000_106.10.758.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2014.07.011"},{"key":"2025092000532464000_106.10.758.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.01.087"},{"key":"2025092000532464000_106.10.758.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.11.096"},{"key":"2025092000532464000_106.10.758.7","unstructured":"De Bruyne B , Pijls NHJ , Kalesan B , et al . Fractional Flow Reserve\u2013Guided PCI versus Medical Therapy in Stable Coronary Disease [Internet], 2012. Available: https:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa1205361?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dwww.ncbi.nlm.nih.gov [Accessed 4 Mar 4 2019]."},{"key":"2025092000532464000_106.10.758.8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.031907"},{"key":"2025092000532464000_106.10.758.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.07.973"},{"key":"2025092000532464000_106.10.758.10","doi-asserted-by":"publisher","DOI":"10.1002\/clc.20693"},{"key":"2025092000532464000_106.10.758.11","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.21406"},{"key":"2025092000532464000_106.10.758.12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1253\/circj.CJ-14-0671","article-title":"Long-Term outcome after deferral of revascularization in patients with intermediate coronary stenosis and Gray-Zone fractional flow reserve","volume":"79","author":"Shiono","year":"2014","journal-title":"Circ J"},{"key":"2025092000532464000_106.10.758.13","first-page":"6","article-title":"Clinical Decision-Making for the Hemodynamic \u201cGray Zone\u201d (FFR 0.75-0.80) and Long-Term Outcomes","volume":"29","author":"Agarwal","year":"2017","journal-title":"J INVASIVE Cardiol"},{"key":"2025092000532464000_106.10.758.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.03.004"},{"key":"2025092000532464000_106.10.758.15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12928-014-0302-4","article-title":"Seven-year clinical outcomes of patients with moderate coronary artery stenosis after deferral of revascularization based on gray-zone fractional flow reserve","volume":"30","author":"Yamashita","year":"2015","journal-title":"Cardiovasc Interv Ther"},{"key":"2025092000532464000_106.10.758.16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.018747"},{"key":"2025092000532464000_106.10.758.17","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1093\/eurheartj\/ehy079","article-title":"Deferred vs. performed revascularization for coronary stenosis with grey-zone fractional flow reserve values: data from the IRIS-FFR registry","volume":"39","author":"Kang","year":"2018","journal-title":"Eur Heart J"},{"key":"2025092000532464000_106.10.758.18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.12680"},{"key":"2025092000532464000_106.10.758.19","unstructured":"Sechtem U , Achenbach S , Andreotti F , et al . 2013 ESC guidelines on the management of stable coronary artery disease\u2014addenda 2013;32."},{"key":"2025092000532464000_106.10.758.20","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2013-305124"},{"key":"2025092000532464000_106.10.758.21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00392-016-1047-0","article-title":"The assessment of ischaemic burden: validation of a functional jeopardy score against cardiovascular magnetic resonance perfusion imaging","volume":"106","author":"Hussain","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"2025092000532464000_106.10.758.22","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)00397-9"},{"key":"2025092000532464000_106.10.758.23","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.4244\/EIJV13I2A20","article-title":"Coronary physiological parameters at a crossroads","volume":"13","author":"Davies","year":"2017","journal-title":"EuroIntervention"},{"key":"2025092000532464000_106.10.758.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32714-9"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2019-316075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T07:53:34Z","timestamp":1758354814000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2019-316075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,29]]},"references-count":24,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,4,23]]},"published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.1136\/heartjnl-2019-316075"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2019-316075","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,29]]}}}